人工肌腱和韌帶市場規模、佔有率、成長分析、按植入類型、按應用、按最終用戶、按地區 - 行業預測 2025-2032

2023 年全球人工肌腱和韌帶市場規模價值 111 億美元，預計將從 2024 年的 126.1 億美元成長到 2032 年的 349.7 億美元，預測期內（2025-2032 年）的複合年成長率為 13.6%。

由於對微創手術的需求不斷增加以及對運動傷害的認知不斷提高，人工韌帶市場預計將顯著成長。人工韌帶的設計主要考慮因素包括機械性能、材料選擇以及臨床試驗的全面評估。尤其令人擔憂的是運動相關傷害的發生率很高，2019 年英國報告的運動相關傷害發生率達 165,000 起，凸顯了對有效解決方案的需求。合成材料的創新對於克服傳統植入方法相關的併發症（例如斷裂和膝蓋不適）至關重要。產業相關人員和研發機構積極致力於研發能夠與天然組織結合並促進癒合的先進合成植入物。纖維增強水凝膠等有前景的發展已經出現，增加了市場的成長潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

人工肌腱和韌帶市場規模（以植入類型）

• 市場概況
• 矽膠棒植入
• 瑪萊克斯網
• 碳纖維植入
• 其他

人工肌腱和韌帶市場規模（依應用）

• 市場概況
• 膝蓋受傷
• 肩部受傷
• 足部和踝部損傷
• 脊髓損傷
• 髖關節損傷
• 其他

人工肌腱和韌帶市場規模（按最終用戶分類）

• 市場概況
• 醫院
• 專科門診
• 門診手術中心
• 其他

人工肌腱和韌帶市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Smith+Nephew（United Kingdom）
• Zimmer Biomet（United States）
• Xiros Ltd.（Neoligaments）（United Kingdom）
• Orthomed SAS（France）
• Shanghai PINE&POWER Biotech（China）
• Arthrex Inc.（United States）
• Corin Group（United Kingdom）
• Enovis Corporation（Mathys AG Bettlach）（Switzerland）
• Stryker Corporation（United States）
• GROUP FH ORTHO（France）
• FX Solutions（France）
• LARS（Corin Group）（France）
• Cousin Biotech（France）
• Mathys AG Bettlach（Switzerland）
• Ossur hf（Iceland）
• Integra LifeSciences Holdings Corporation（United States）
• Medtronic plc（Ireland）
• Orthonika, Inc.（United Kingdom）
• United Orthopedic Corporation（Taiwan）

結論和建議

Global Artificial Tendons And Ligaments Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.61 billion in 2024 to USD 34.97 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The artificial ligament market is poised for significant growth due to increasing demand for minimally invasive procedures and heightened awareness of sports injuries. Key design considerations for these products include mechanical performance, material selection, and thorough evaluation during clinical studies. A notable concern is the high incidence of sports-related injuries, with 165,000 cases reported in England in 2019, underscoring the need for effective solutions. Innovations in synthetic materials are critical to overcoming the complications associated with traditional graft methods, such as tendon rupture and knee discomfort. Industry players and research institutions are actively engaged in R&D to develop advanced synthetic grafts that can blend with natural tissues and promote healing. Promising developments, such as fiber-reinforced hydrogels, are emerging, reinforcing the market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Tendons And Ligaments market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Tendons And Ligaments Market Segmental Analysis

Global Artificial Tendons And Ligaments Market is segmented by Implant Type, Application, End User and region. Based on Implant Type, the market is segmented into Silastic-rod implant, Marlex mesh, Carbon-Fibre implant and Others. Based on Application, the market is segmented into Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Tendons And Ligaments Market

A key factor driving the Global Artificial Tendons and Ligaments market is the surge in sports injuries, which primarily arise from accidents, improper techniques, inadequate warm-ups, stretching, and poor conditioning. Many athletes experience common injuries such as tennis elbow, ankle sprains, groin pulls, hamstring strains, and ACL tears. Especially in developed countries like the U.S. and the U.K., the rising incidence of these sports-related injuries is expected to significantly boost the demand for artificial tendons and ligaments. Moreover, the increasing acceptance of minimally invasive surgical techniques for tendon and ligament reconstruction is fostering market growth, as patients increasingly prefer less painful surgical options. Progress in knee replacement procedures further enhances clinical opportunities, indicating a promising trajectory for the market's expansion in the near future.

Restraints in the Global Artificial Tendons And Ligaments Market

The growth of the Global Artificial Tendons and Ligaments market is anticipated to be hindered by escalating research and development expenses during the forecast period. Furthermore, safety and regulatory challenges are likely to pose significant obstacles in the near future. Healthcare providers exhibit hesitance towards the adoption of artificial tendons and ligaments, primarily due to the prohibitive costs linked to the procedures and a lack of favorable reimbursement policies. Additionally, the clinical efficacy of these artificial implants is compromised by various risks, with synovial membrane inflammation standing out as a major concern among patients undergoing treatment.

Market Trends of the Global Artificial Tendons And Ligaments Market

The Global Artificial Tendons and Ligaments market exhibits a compelling trend toward the knee injury segment, projected to dominate market share due to rising sports participation rates, leading to a surge in knee injuries. This trend is further fueled by patient dissatisfaction with traditional surgical approaches using allografts, which can result in prolonged recovery and availability issues. Innovations in artificial ligaments provide significant advantages, including reduced recovery times, enhanced availability, and expedited surgical procedures compared to donor tendon grafts. As a result, healthcare professionals and patients are increasingly favoring these advanced solutions, solidifying the segment's leading position in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Artificial Tendons And Ligaments Market Size by Implant Type & CAGR (2025-2032)

• Market Overview
• Silastic-rod implant
• Marlex mesh
• Carbon-Fibre implant
• Others

Global Artificial Tendons And Ligaments Market Size by Application & CAGR (2025-2032)

• Market Overview
• Knee Injuries
• Shoulder Injuries
• Foot & Ankle Injuries
• Spine Injuries
• Hip Injuries
• Others

Global Artificial Tendons And Ligaments Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centres
• Others

Global Artificial Tendons And Ligaments Market Size & CAGR (2025-2032)

• North America (Implant Type, Application, End User)
  • US
  • Canada
• Europe (Implant Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Implant Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Implant Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Implant Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Smith+Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xiros Ltd. (Neoligaments) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthomed S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai PINE&POWER Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation (Mathys AG Bettlach) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GROUP FH ORTHO (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FX Solutions (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LARS (Corin Group) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cousin Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mathys AG Bettlach (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur hf (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthonika, Inc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Orthopedic Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations